Patrick Griffin

Relmada Therapeutics joins the Russell 2000, a key validation that opens doors to new capital. But can its high-stakes pipeline deliver on this promise?

The Energy and Mines Ministers' Conference concludes, signaling a strategic pivot to northern infrastructure, critical minerals, and Indigenous partnership.

A simple cookie dough recall from Bear Stewart reveals a deeper crisis in food supply chains. A packaging error is the cause, but the implications are far wider.

Nomic Bio and the HESI OASIS Consortium partner to map liver toxicity using proteomics, fueling AI models to make drug development safer and more ethical.

With its new cellular backup service, insurgent provider Kinetic isn't just selling speed; it's selling resilience. Is this the new front in the war for subscribers?

The Countdown 250 Ball, featuring Lee Greenwood, is more than a party. It's a strategic fusion of cultural legacy and futuristic vision defining the 2026 landscape.

A strategic partnership between a global asset giant and a regional specialist reveals a seismic shift in capital allocation towards underserved markets.

Triller's audacious acquisition of a SpaceX stake sends its stock soaring, but can this high-stakes bet on a space giant save a company plagued by financial woes?

The recent award for Firstup's AI Search is more than a trophy; it's a signal that the AI revolution is finally reaching the frontline workforce.

Euna Solutions is set to unveil a purpose-built AI suite at the GFOA conference, signaling a major shift from AI theory to practical application in government finance.

IBM unveils a 0.7nm chip with a revolutionary 'nanostack' 3D architecture, packing 100 billion transistors and promising a new decade for Moore's Law.

OpenVC's new Unicorn Fund isn't just another fund; it's a systematic attempt to map and monetize the private market frontier where real value now grows.

A new partnership between UVeye and MVT uses AI scanners to overhaul truck maintenance, promising a future of safer roads and more resilient logistics.

A new SoHo pop-up isn't just selling robots; it's selling the future. We explore the strategy behind KOID SHOP and what it means for commerce.

A new RNA therapy for obesity is advancing in trials. It promises to reduce harmful visceral fat, preserve muscle, and may only require a twice-yearly dose.

The value retailer's 2026 food drive reveals a sophisticated new model, blending national scale with local impact to redefine corporate philanthropy.

As Starlight Investments tops off a new rental project, its infill strategy offers a glimpse into how Toronto might build its way out of a housing crisis.

Blackbird Health's expansion into Bala Cynwyd is more than a new clinic; it's a strategic move into a pediatric mental healthcare market at its breaking point.

PetVivo's acquisition of PiezoBioMembrane signals a bold leap from animal care to human health, leveraging advanced biomaterials to chase a larger market.

Memory giant Kioxia's sponsorship of the Asian Games eSports event is more than a logo splash—it's a strategic bet on the future of competitive sport.